These miRNAs affect neuronal viability and synaptic function in AD by modulating the production of neuronal nitric oxide synthase (NOS1) and reducing Aβ-induced toxicity through inhibition of NOS1 expression (Wang et al., 2017; Chen M. et al., 2020). This evidence concerns the gene NOS1 and Alzheimer disease.